Towards Healthcare
AI in Pharmaceuticals Market to Grow at 27.01% till 2035

AI in Pharmaceuticals Market Unlocking Precision Drug Design with Future Therapies

Projections indicate that, AI in pharmaceuticals industry is projected to rise from USD 1.97 billion in 2025 to USD 21.51 billion by 2035, reflecting a CAGR of 27.01% over the next decade. The AI in the pharmaceutical market is growing as demand for pharmaceuticals rises amid chronic conditions & rare diseases. North America’s dominance can be attributed to the rise in clinical trials.

Content

  • Last Updated: 14 November 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

The AI in pharmaceuticals market is valued at USD 2.5 billion in 2026 and is on track to reach USD 21.51 billion by 2035, witnessing a steady CAGR of 27.01% during the forecast span.

North America is currently leading the AI in pharmaceuticals market share by 46% due to the presence of the largest pharmaceutical industry in the region.

The AI in pharmaceuticals market includes 6 segments such as application, technology, drug type, deployment mode, end-user, and region.

Key trends include technological advancements across various processes in pharmaceutical development and a high demand for biologics & biopharmaceuticals.

Pharmacists can identify drug interactions, recommend alternative therapies, and highlight possible safety issues by ingesting and analyzing vast amounts of patient data with the aid of AI-powered clinical decision support tools.

Ministry of Health and Family Welfare, Government of India; National Institutes of Health, FDA, WHO, PIB, CDC, ClinicalTrials.gov, NCBI.
Any Questions